IDEAS home Printed from https://ideas.repec.org/
MyIDEAS: Login to save this article or follow this journal

The Effect of Changes in Treatment Patterns on Drug Expenditure

  • Ulf-G. Gerdtham

    (Centre for Health Economics, Stockholm School of Economics, Stockholm, Sweden)

  • Magnus Johannesson

    (Centre for Health Economics, Stockholm School of Economics, Stockholm, Sweden)

  • Bo Gunnarsson

    (Apoteksbolaget AB, Stockholm, Sweden)

  • Margareta Marcusson

    (Apoteksbolaget AB, Stockholm, Sweden)

  • Freddie Henriksson

    (Centre for Health Economics, Stockholm School of Economics, Stockholm, Sweden)

This paper investigates the effects of changes in drug therapy on drug expenditure in Sweden between 1990 and 1995. Analyses have been carried out for both the aggregate drug expenditure and for drug expenditure according to the main groups of the Anatomical Therapeutic Chemical (ATC) classification system. Changes in expenditure can be divided into 3 components: the price of drugs, the quantity of drugs consumed and a residual. The size of the residual is a measure of the effect of changes in drug treatment patterns on drug expenditure. The aggregate real drug expenditure increased by 50% between 1990 and 1995. The relative retail price index of drugs decreased by 9% and the quantity index measured in terms of defined daily doses increased by 27%. The remaining residual increased by 30%. This implies that, if the residual had been unchanged during the study period, the aggregate expenditure would have increased by only 15%. The results also show that the size of the residual varies substantially across different ATC groups. The increase in the residual was largest for drugs that affect the nervous system (ATC group N); the residual increased by 86%. From the observed changes in residual values, it can be concluded that the underlying factor responsible for the increase in drug expenditure in Sweden is changes in drug therapy from less expensive to more expensive drugs.

If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

File URL: http://pharmacoeconomics.adisonline.com/pt/re/phe/pdfhandler.00019053-1998131Pr20-00012.pdf
Download Restriction: Pay per view

File URL: http://pharmacoeconomics.adisonline.com/pt/re/phe/fulltext.00019053-1998131Pr20-00012.htm
Download Restriction: Pay per view

As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.

Article provided by Springer Healthcare | Adis in its journal PharmacoEconomics.

Volume (Year): 13 (1998)
Issue (Month): 1 Part 2 ()
Pages: 127-134

as
in new window

Handle: RePEc:wkh:phecon:v:13:y:1998:i:1-part-2:p:127-134
Contact details of provider: Web page: http://pharmacoeconomics.adisonline.com/

No references listed on IDEAS
You can help add them by filling out this form.

This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

When requesting a correction, please mention this item's handle: RePEc:wkh:phecon:v:13:y:1998:i:1-part-2:p:127-134. See general information about how to correct material in RePEc.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Dave Dustin)

If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

If references are entirely missing, you can add them using this form.

If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

Please note that corrections may take a couple of weeks to filter through the various RePEc services.

This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.